Search Results - Tom White
- Showing 1 - 8 results of 8
-
1
-
2
-
3
Estimating vaccine efficacy during open-label follow-up of COVID-19 vaccine trials based on population-level surveillance data by Mia Moore, Yifan Zhu, Ian Hirsch, Tom White, Robert C. Reiner, Ryan M. Barber, David Pigott, James K. Collins, Serena Santoni, Magdalena E. Sobieszczyk, Holly Janes
Published in Epidemics (2024-06-01)Get full text
Article -
4
Serum AZD7442 (tixagevimab–cilgavimab) concentrations and in vitro IC50 values predict SARS‐CoV‐2 neutralising antibody titres by Lindsay E Clegg, Oleg Stepanov, Sam Matthews, Tom White, Seth Seegobin, Steven Thomas, Kevin M Tuffy, Mats Någård, Mark T Esser, Katie Streicher, Taylor S Cohen, Anastasia A Aksyuk
Published in Clinical & Translational Immunology (2024-01-01)Get full text
Article -
5
Imaging of Light-Enhanced Extracellular Vesicle-Mediated Delivery of Oxaliplatin to Colorectal Cancer Cells via Laser Ablation, Inductively Coupled Plasma Mass Spectrometry by Kara Chandler, Josh Millar, George Ward, Christopher Boyall, Tom White, Joseph David Ready, Rawan Maani, Keith Chapple, Robert Tempest, Joseph Brealey, Catherine Duckett, Sarah Haywood-Small, Simon Turega, Nick Peake
Published in Cells (2023-12-01)Get full text
Article -
6
Large Scale Population Assessment of Physical Activity Using Wrist Worn Accelerometers: The UK Biobank Study. by Aiden Doherty, Dan Jackson, Nils Hammerla, Thomas Plötz, Patrick Olivier, Malcolm H Granat, Tom White, Vincent T van Hees, Michael I Trenell, Christoper G Owen, Stephen J Preece, Rob Gillions, Simon Sheard, Tim Peakman, Soren Brage, Nicholas J Wareham
Published in PLoS ONE (2017-01-01)Get full text
Article -
7
A SARS-CoV-2 variant‑adjusted threshold of protection model for monoclonal antibody pre-exposure prophylaxis against COVID-19 by Rhiannon Edge, Sam Matthews, Bahar Ahani, Anastasia A. Aksyuk, Lindsay Clegg, John L. Perez, Mark T. Esser, Lee-Jah Chang, Ian Hirsch, Tonya Villafana, John Pura, Oleg Stepanov, Katie Streicher, Tom White, Taylor S. Cohen, Dean Follmann, Peter B. Gilbert, Seth Seegobin
Published in Nature Communications (2025-10-01)Get full text
Article -
8
Durability of protection and immunogenicity of AZD1222 (ChAdOx1 nCoV-19) COVID-19 vaccine over 6 months by Magdalena E. Sobieszczyk, Jill Maaske, Ann R. Falsey, Stephanie Sproule, Merlin L. Robb, Robert W. Frenck Jr., Hong-Van Tieu, Kenneth H. Mayer, Lawrence Corey, Kathleen M. Neuzil, Tina Tong, Margaret Brewinski Isaacs, Holly Janes, Himanshu Bansal, Lindsay M. Edwards, Justin A. Green, Elizabeth J. Kelly, Kathryn Shoemaker, Therese Takas, Tom White, Prakash Bhuyan, Tonya Villafana, and Ian Hirsch, on behalf of the AstraZeneca AZD1222 Clinical Study Group
Published in The Journal of Clinical Investigation (2022-09-01)Get full text
Article
